Efficacy and safety of black pepper in lowering blood lipid levels in patients with dyslipidemia

MFU research funding0 个研究点目标入组 44 人开始时间: 2024年6月18日最近更新: 2024年8月19日

适应症

试验速览

阶段: 2 期
状态: 已完成
发起方
入组人数: 44

研究概览入排标准研究者记录与标识符相似试验

研究概览

简要总结

暂无简介。

研究设计

研究类型: Interventional

入排标准

年龄范围: 20 Years 至 60 Years（—）
性别: All

入选标准

•Volunteers will be eligible to participate in the research if they meet the following criteria:
•1. Volunteers of both genders
•1.1) Aged between 20-34 years with abnormal blood lipid levels, specifically LDL-C levels between 130-189 mg/dL, HDL-C levels less than 40 mg/dL in females or less than 50 mg/dL in males, and triglycerides levels < 400 mg/dL, or
•1.2) Aged between 35-60 years with abnormal blood lipid levels, specifically LDL-C levels between 100-130 mg/dL, HDL-C levels less than 40 mg/dL in females or less than 50 mg/dL in males, and triglycerides levels < 400 mg/dL
•2. Body mass index (BMI) between 18-35 kg/m2
•3. Diagnosed as a first-time high blood cholesterol patient by the current physician
•4. At risk of heart and vascular diseases with a 10-year risk assessment using the Thai CV Risk Score of less than 10%
•5. Effective communication skills
•6. Willing and able to comply with the study requirements

排除标准

•Volunteers will not be eligible to participate in the research if they have:
•1. Abnormal blood lipid levels due to hypothyroidism, nephrotic syndrome, or impaired kidney function (serum creatinine > 1.5 milligrams per deciliter), or have Type 1 or uncontrolled Type 2 diabetes.
•2. Consumed other herbal remedies, medications, or dietary supplements affecting blood lipid levels such as steroids, tegretol, cyclosporine, fish oil, fibrates, cholesterol absorption inhibitors, niacin, bile acid sequestrants, statins, probucol, thiazides, progestogens, estrogens, testosterone, beta-blockers, glucocorticoids, etc., that cannot be discontinued.
•3. Systolic blood pressure greater than or equal to 130 millimeters of mercury (mm Hg) or diastolic blood pressure greater than or equal to 80 mm Hg.
•4. Not taken antihypertensive medications or heart disease medications.
•5. Participated in other research projects (except for non-interfering studies such as surveys).
•6. A history of allergy to black pepper or other herbal remedies.
•7. High-risk factors for heart and vascular diseases, including existing coronary artery disease and other conditions equivalent to heart disease, such as ischemic stroke, transient ischemic attack, peripheral artery disease, aortic aneurysm, etc.
•8. Liver cancer or liver function greater than the standard criteria, or impaired kidney function defined as a glomerular filtration rate (GFR) less than 60 milliliters per minute per 1.73 square meters (ml/min/1.73 m2).
•9. Taken weight-reducing medications in the past 6 months.
•10. Engaged in regular strenuous physical activity.
•11. Strictly controlled their diet.
•12. Pregnant, planning to become pregnant, breastfeeding, or unwilling to use medically acceptable birth control methods while participating in the study.

研究者

发起方

MFU research funding

相似试验

招募中

3 期

the effect of combined herbal capsule on covid-19 disease

IRCT20210804052068N1Shooshtar University of Medical Sciences30

已完成

不适用

Effect of Topical Application of Black Pepper Essential Oil and Peripheral Catheter InsertionPatient SatisfactionNurse Scope, PracticeSpasm Vein

NCT04796805University of Yalova60

已完成

不适用

Olfactory stimulation using black pepper oil effects the clinical symptoms of geriatric syndrome in nursing home elderlyhealth-care associated pneumonia, fall, dementia

JPRN-UMIN000003918Institute of Developement,Aging & Cancer,Tohoku University150

已完成

不适用

Examination of the Effects of Long Pepper Extract on Blood Flow and Skin Surface Temperature Following the Exposure to Cold Water Stress: Placebo controlled, Randomized, Double-blind, Cross-over Study/A (healthy adults)

JPRN-UMIN000025893TES Holdings Co., Ltd.30

已完成

不适用

JPRN-UMIN000021687TES Holdings Co., Ltd30